Rationale: Patients with Mycobacterium avium complex pulmonary disease are frequently
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …

Objectives Chemotherapy-induced nausea and vomiting (CINV) is an unanswered problem
in cancer therapy. We evaluated the efficacy and safety of triple antiemetic therapy with …

Objectives Single agent maintenance therapy is widely accepted for advanced non-squamous
non small cell lung cancer (NSCLC). However, there is no consensus on the initial and …

Background Some patients with idiopathic interstitial pneumonia (IIP) show autoimmune
features. Interstitial pneumonia with autoimmune features (IPAF) was recently proposed as a …

In patients with chronic eosinophilic pneumonia (CEP), dramatic improvements are seen in
response to corticosteroid therapy; however, relapse is common after treatment has ceased. …

Background Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor, has
been shown to improve survival in non-small cell lung cancer (NSCLC). The possible …

Background Chronic eosinophilic pneumonia (CEP) is characterized by the accumulation of
eosinophils in the lung with unknown etiology. Although systemic corticosteroid …

The purpose of this article was to report the relationship between radiation dose and the ability
of sentence digital mammography to detect microcalcifications. All images were acquired …

Purpose The optimal strategy for maintenance chemotherapy is controversial. We evaluated
the efficacy and safety of continuation maintenance with pemetrexed and switch …

Background Patients with idiopathic interstitial pneumonia (IIP) have a favourable prognosis
when they have interstitial pneumonia with autoimmune features (IPAF). However, precise …